0001592052-13-000002.txt : 20131203
0001592052-13-000002.hdr.sgml : 20131203
20131203112706
ACCESSION NUMBER: 0001592052-13-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20131203
DATE AS OF CHANGE: 20131203
EFFECTIVENESS DATE: 20131203
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Centrexion Corp
CENTRAL INDEX KEY: 0001592052
IRS NUMBER: 320402377
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-207282
FILM NUMBER: 131253613
BUSINESS ADDRESS:
STREET 1: 509 S. EXETER ST., SUITE 202
CITY: BALTIMORE
STATE: MD
ZIP: 21202
BUSINESS PHONE: 212-956-1111
MAIL ADDRESS:
STREET 1: 509 S. EXETER ST., SUITE 202
CITY: BALTIMORE
STATE: MD
ZIP: 21202
D
1
primary_doc.xml
X0707
D
LIVE
0001592052
Centrexion Corp
509 S. EXETER ST., SUITE 202
BALTIMORE
MD
MARYLAND
21202
410-522-8701
DELAWARE
None
None
Corporation
true
2013
Sol
Barer
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Director
Isaac
Blech
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Director
Kerrie
L.
Brady
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Executive Officer
James
N.
Campbell
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Executive Officer
Director
Jeffrey
B.
Kindler
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Executive Officer
Arnold
L.
Oronsky
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Director
Biotechnology
Decline to Disclose
- 06b
false
2013-11-20
false
true
true
Series A Convertible Preferred Stock
true
5,000,000 shares issued in connection with a merger and an asset purchase.
0
8750000
8750000
0
Series A Convertible Preferred Stock issued as consideration in a merger transaction and an asset purchase transaction.
false
20
0
0
0
true
false
Centrexion Corp
/s/ Sol Barer
Sol Barer
Authorized Person
2013-12-03